Pitavastatin Impurity 4 | CAS 1187966-95-5 - Request Quote
Pitavastatin Impurity 4
| SZ CAT No: | SZ-P023038 |
| CAS No | 1187966-95-5 |
| Mol.F. | C20H14FN |
| Mol.Wt. | 287.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pitavastatin Impurity 4 is chemically 6-Cyclopropyl-10-fluorobenzo[k]phenanthridine. Pitavastatin Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Pitavastatin Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pitavastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1187966-95-5
Purchase 1187966-95-5
Order 1187966-95-5
Enquire 1187966-95-5
price of 1187966-95-5
1187966-95-5 Supplier
1187966-95-5 Manufacturer
1187966-95-5 Exporter
buy high quality Pitavastatin Impurity 4
Purchase Pitavastatin Impurity 4
Pitavastatin Impurity 4 suppliers
Pitavastatin Impurity 4 manufacturers
Pitavastatin Impurity 4 price
Order Pitavastatin Impurity 4
Enquire Pitavastatin Impurity 4
Pitavastatin Impurity 4 cost
Pitavastatin Impurity 4 Supplier
Pitavastatin Impurity 4 Distributor
Pitavastatin Impurity 4 for Method Validation
Pitavastatin Reference Standard
Pitavastatin Impurity 4 for ANDA Filing
Pitavastatin Impurity 4 for Forced Degradation Studies
Pitavastatin Impurity 4 Identification Standards
Pitavastatin Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.